Lord, Abbett & Co’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-132,426
| Closed | -$1.73M | – | 658 |
|
|
2022
Q3 | $1.73M | Hold |
132,426
| – | – | 0.01% | 541 |
|
|
2022
Q2 | $1.7M | Sell |
132,426
-800
| -0.6% | -$10.3K | 0.01% | 543 |
|
|
2022
Q1 | $2.03M | Sell |
133,226
-52,375
| -28% | -$799K | 0.01% | 586 |
|
|
2021
Q4 | $3.29M | Buy |
185,601
+200
| +0.1% | +$3.54K | 0.01% | 576 |
|
|
2021
Q3 | $3.9M | Sell |
185,401
-3,700
| -2% | -$77.8K | 0.01% | 606 |
|
|
2021
Q2 | $3.73M | Buy |
+189,101
| New | +$3.73M | 0.01% | 617 |
|